St Gallen Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.

Joseph dimasiOliver gassmanTechnische hochschule ingolstadtAlexander schuhmacherJoseph dimasi at tufts universitySt gallen consortiumUniversity of stMore researchNature reviews drug discoveryTufts universityDrug discovery todayPer newInsilico medicineBig pharmaPharmaceutical industryR ampd productivity